Login Create Account

Powerpack

Unlock full stockrow access for only $7.9/month and boost yourself as an investor.

  • Watchlist

    Keep track of companies that you follow and research.

  • 10 Years of Data

    Full access to our data with predictions and indicators that we calculate daily.

  • Screener

    Full access to our screener with tons of custom values and customizable email notifications.

  • XLS Exports

    Excel export of financials and screeners you define and save.

Subscribe now
Screener Weekly Summary

Larimar Therapeutics, Inc. LRMR

Healthcare  —  Biotechnology
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Analyst Commentary Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending)

Financial statements are limited to most recent four years or quarters for non-powerpack users

Ten years worth of data (where available), most important trends and XLS exports are available for our Powerpack users.

Register an account and get your Powerpack now or Login

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Jan '22 Dec '21 Jan '21 Dec '20 Jan '20 Dec '19 Jan '19 Dec '18 Jan '18 Dec '17 Jan '17 Dec '16 Jan '16
Cash and Short Term Investments 136.85 183.45 86.79 118.43 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Receivables — — — — — — ‡‡‡‡‡ — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Other current assets — — — — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡
Total current assets 142.02 195.30 90.18 120.74 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Property, Plant, Equpment (Net) 0.62 0.88 0.68 0.83 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Long-Term Investments — — — — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — — — — — — — —
Long-term assets (Other) 1.13 1.20 2.00 1.98 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Total non-current assets 3.82 4.92 5.76 5.67 — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ —
Total Assets 145.84 200.23 95.94 126.41 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Notes Payable — — — — — — — — — ‡‡‡‡‡ — ‡‡‡‡‡ — — — ‡‡‡‡‡ —
Accounts Payable 5.22 2.42 1.28 1.69 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ — ‡‡‡‡‡ —
Accrued Expenses 58.47 20.87 7.39 8.41 — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ —
Current Part of Debt — — — — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ — ‡‡‡‡‡ — — — ‡‡‡‡‡
Other current liabilities — — — — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡
Total current liabilities 64.80 24.36 9.51 10.71 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Long Term Debt (Total) — — — — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ ‡‡‡‡‡ — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ — —
Non-current Liabilities (Other) — — — — — — — — — — — — — — ‡‡‡ — —
Total non-current liabilities 2.96 4.06 4.71 4.80 — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — — —
Total liabilities 67.76 28.41 14.22 15.50 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Additional Paid In Capital 512.78 440.76 270.15 262.50 — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ —
Common Stock (Net) 0.08 0.06 0.04 0.04 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Retained Earnings (434.83) (269.16) (188.55) (151.60) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Common Equity (Total) 78.09 171.81 81.72 110.90 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shareholders Equity (Total) 78.09 171.81 81.72 110.90 ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Shareholders Equity and Liabilities (Total) 145.84 200.23 95.94 126.41 — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ —
Shares (Common) 83.09 63.82 43.91 43.27 — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ —
Shareholders Equity (Tangible) 78.09 171.81 81.72 110.90 — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ —
Net Debt (136.85) (183.45) (86.79) (118.43) ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡
Total Debt — — — — ‡‡‡‡‡ — ‡‡‡‡‡ — ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ ‡‡‡‡‡ — ‡‡‡‡‡